Researchers predict that climate change will likely cause a sharp rise in heat-related mortality throughout Europe by the end of this century.
Fostamatinib Fails to Improve Outcomes in Hypoxemic COVID Patients
The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, according to a phase III trial published